Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
29.71 USD | -3.57% | -3.99% | 0.00% |
May. 14 | Goldman Sachs Upgrades CG Oncology to Buy From Neutral With $50 Price Target | MT |
May. 09 | CG Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
- Stock Market
- Equities
- CGON Stock
- News CG Oncology, Inc.